Market Closed -
Nyse
04:00:02 2024-05-10 pm EDT
|
5-day change
|
1st Jan Change
|
34.06
USD
|
-0.09%
|
|
+1.82%
|
+6.04%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,780
|
1,527
|
1,344
|
1,439
|
1,330
|
1,481
|
-
|
-
|
Enterprise Value (EV)
1 |
2,469
|
2,169
|
2,062
|
2,197
|
2,201
|
2,355
|
2,349
|
2,344
|
P/E ratio
|
22.2
x
|
16.1
x
|
24.2
x
|
14.3
x
|
14.9
x
|
17.4
x
|
18
x
|
18.2
x
|
Yield
|
5.09%
|
5.86%
|
6.68%
|
6.42%
|
7.1%
|
6.71%
|
6.72%
|
6.71%
|
Capitalization / Revenue
|
9.6
x
|
9.58
x
|
8.65
x
|
8.22
x
|
6.74
x
|
7.32
x
|
7.15
x
|
-
|
EV / Revenue
|
13.3
x
|
13.6
x
|
13.3
x
|
12.5
x
|
11.2
x
|
11.6
x
|
11.3
x
|
-
|
EV / EBITDA
|
16.2
x
|
17.4
x
|
17.4
x
|
16.2
x
|
13.9
x
|
14.4
x
|
14.2
x
|
14.8
x
|
EV / FCF
|
-
|
19,778,593
x
|
23,229,319
x
|
22,741,120
x
|
23,239,488
x
|
-
|
-
|
-
|
FCF Yield
|
-
|
0%
|
0%
|
0%
|
0%
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
1.81
x
|
1.72
x
|
1.57
x
|
1.58
x
|
1.53
x
|
1.49
x
|
Nbr of stocks (in thousands)
|
39,752
|
39,242
|
39,374
|
40,505
|
41,412
|
43,475
|
-
|
-
|
Reference price
2 |
44.77
|
38.91
|
34.14
|
35.53
|
32.12
|
34.06
|
34.06
|
34.06
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/16/23
|
2/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
185.3
|
159.3
|
155.3
|
175.2
|
197.2
|
202.3
|
207.1
|
-
|
EBITDA
1 |
152.5
|
124.6
|
118.5
|
135.9
|
158.2
|
163.7
|
166.5
|
158.6
|
EBIT
1 |
-
|
85.49
|
80.17
|
99.08
|
89.96
|
83.32
|
96.55
|
117.5
|
Operating Margin
|
-
|
53.65%
|
51.62%
|
56.57%
|
45.61%
|
41.19%
|
46.61%
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-
|
56.22
|
99.08
|
89.96
|
78.01
|
79.38
|
77.59
|
Net income
1 |
80.14
|
94.87
|
55.4
|
99.44
|
89.15
|
85.31
|
85.14
|
82.9
|
Net margin
|
43.25%
|
59.54%
|
35.67%
|
56.78%
|
45.2%
|
42.17%
|
41.1%
|
-
|
EPS
2 |
2.020
|
2.420
|
1.410
|
2.480
|
2.160
|
1.922
|
1.884
|
1.871
|
Free Cash Flow
|
-
|
109.6
|
88.76
|
96.59
|
94.72
|
-
|
-
|
-
|
FCF margin
|
-
|
68.81%
|
57.14%
|
55.15%
|
48.02%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
88.02%
|
74.92%
|
71.06%
|
59.87%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
115.57%
|
160.2%
|
97.13%
|
106.25%
|
-
|
-
|
-
|
Dividend per Share
2 |
2.280
|
2.280
|
2.280
|
2.280
|
2.280
|
2.284
|
2.290
|
2.285
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/16/23
|
2/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
39.44
|
40.79
|
43.02
|
43.5
|
47.84
|
49.5
|
48.25
|
49.3
|
50.2
|
51.37
|
49.43
|
50.33
|
51.17
|
50.66
|
51.86
|
EBITDA
1 |
29.99
|
31
|
33.37
|
33.46
|
38.44
|
39.91
|
38.97
|
40.07
|
40.5
|
41.49
|
40.46
|
41.12
|
42.14
|
40.67
|
41
|
EBIT
1 |
20.54
|
-
|
23.99
|
29.58
|
17.82
|
30.7
|
6.228
|
22.25
|
28.29
|
32.4
|
18.62
|
19.52
|
20.87
|
23.29
|
23.96
|
Operating Margin
|
52.08%
|
-
|
55.75%
|
68%
|
37.25%
|
62.03%
|
12.91%
|
45.13%
|
56.37%
|
63.07%
|
37.66%
|
38.79%
|
40.78%
|
45.96%
|
46.21%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
54.11
|
13.39
|
17.82
|
33.56
|
-
|
-
|
28.29
|
24.69
|
19.36
|
19.5
|
19.97
|
19.85
|
20.16
|
Net income
1 |
12.73
|
14.28
|
54.06
|
13.16
|
17.81
|
32.93
|
6.028
|
22.05
|
28.06
|
24.06
|
19.52
|
19.78
|
20.55
|
20.73
|
21.48
|
Net margin
|
32.27%
|
35%
|
125.66%
|
30.25%
|
37.23%
|
66.52%
|
12.49%
|
44.72%
|
55.9%
|
46.85%
|
39.49%
|
39.29%
|
40.16%
|
40.92%
|
41.42%
|
EPS
2 |
0.3200
|
0.3600
|
1.360
|
0.3200
|
0.4400
|
0.8000
|
0.1500
|
0.5400
|
0.6700
|
0.5600
|
0.4534
|
0.4561
|
0.4683
|
0.4622
|
0.4740
|
Dividend per Share
2 |
0.5700
|
0.5700
|
0.5700
|
0.5700
|
0.5700
|
0.5700
|
0.5700
|
0.5700
|
0.5700
|
-
|
0.5700
|
0.5700
|
0.5700
|
0.5700
|
0.5700
|
Announcement Date
|
2/17/22
|
4/28/22
|
7/28/22
|
10/27/22
|
2/16/23
|
4/27/23
|
7/27/23
|
10/26/23
|
2/15/24
|
4/29/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
689
|
642
|
718
|
757
|
871
|
874
|
868
|
864
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
4.518
x
|
5.151
x
|
6.057
x
|
5.572
x
|
5.506
x
|
5.34
x
|
5.215
x
|
5.444
x
|
Free Cash Flow
|
-
|
110
|
88.8
|
96.6
|
94.7
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
10.4%
|
8.84%
|
8.75%
|
8.32%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
5.08%
|
4.3%
|
4.43%
|
4.28%
|
Assets
1 |
-
|
-
|
-
|
-
|
1,756
|
1,985
|
1,923
|
1,936
|
Book Value Per Share
2 |
-
|
-
|
18.80
|
20.70
|
20.50
|
21.60
|
22.20
|
22.80
|
Cash Flow per Share
2 |
-
|
-
|
2.330
|
2.640
|
2.520
|
2.870
|
2.910
|
2.880
|
Capex
|
-
|
6.91
|
6.3
|
8.99
|
9.69
|
-
|
-
|
-
|
Capex / Sales
|
-
|
4.34%
|
4.05%
|
5.13%
|
4.91%
|
-
|
-
|
-
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/16/23
|
2/15/24
|
-
|
-
|
-
|
Last Close Price
34.06
USD Average target price
34
USD Spread / Average Target -0.18% Consensus |
1st Jan change
|
Capi.
|
---|
| +6.04% | 1.48B | | +9.60% | 59.09B | | -4.57% | 19.25B | | -1.26% | 13.76B | | +0.10% | 7.58B | | -10.80% | 5.82B | | +10.32% | 3.51B | | +1.82% | 3.36B | | -1.26% | 3.22B | | +16.92% | 2.84B |
Healthcare REITs
|